122 related articles for article (PubMed ID: 22892121)
21. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
[TBL] [Abstract][Full Text] [Related]
22. What is in the pipeline for Gram-negative pathogens?
Talbot GH
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antibacterial activity of C-4 substituted monobactams.
Mewshaw RE; Commons TJ
J Antibiot (Tokyo); 1987 Nov; 40(11):1563-71. PubMed ID: 3121566
[No Abstract] [Full Text] [Related]
24. Gram-negative superbugs: inappropriate antimicrobial therapy and mortality.
Blondeau J
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):347-9. PubMed ID: 23927660
[No Abstract] [Full Text] [Related]
25. New trends in pharmacogenomic strategies against resistance development in microbial infections.
Ohlsen K; Dandekar G; Schwarz R; Dandekar T
Pharmacogenomics; 2008 Nov; 9(11):1711-23. PubMed ID: 19018725
[TBL] [Abstract][Full Text] [Related]
26. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic.
Oliva A; Giacobbe DR; Di Luca M; Miller NS
Biomed Res Int; 2018; 2018():8905874. PubMed ID: 30671476
[No Abstract] [Full Text] [Related]
27. In vitro activity of tigecycline against multidrug-resistant Gram-negative blood culture isolates from critically ill patients.
Gupta S; Aruna C; Nagaraj S; Dias M; Muralidharan S
J Antimicrob Chemother; 2012 May; 67(5):1293-5. PubMed ID: 22258926
[No Abstract] [Full Text] [Related]
28. Comprehensive 2D-Quantitative Structure-Activity Relationship Study on Monobactam Analogues Against Gram-Negative Bacteria.
Zhang D; Zhang X; Li Z; Tang S; Guo Z; Hu C; Zhang J; Song D; Li Y
J Biomed Nanotechnol; 2020 Jun; 16(6):941-953. PubMed ID: 33187589
[TBL] [Abstract][Full Text] [Related]
29. The synthesis and biological evaluation of some novel aminoheterocyclic methoxime monobactam derivatives.
Wheeler WJ; Finley DR; Ott JL
J Antibiot (Tokyo); 1986 Nov; 39(11):1611-4. PubMed ID: 3793632
[No Abstract] [Full Text] [Related]
30. Methodology for Monobactam Diversification: Syntheses and Studies of 4-Thiomethyl Substituted β-Lactams with Activity against Gram-Negative Bacteria, Including Carbapenemase Producing Acinetobacter baumannii.
Carosso S; Liu R; Miller PA; Hecker SJ; Glinka T; Miller MJ
J Med Chem; 2017 Nov; 60(21):8933-8944. PubMed ID: 28994597
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
32. A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli.
Goldberg JA; Nguyen H; Kumar V; Spencer EJ; Hoyer D; Marshall EK; Cmolik A; O'Shea M; Marshall SH; Hujer AM; Hujer KM; Rudin SD; Domitrovic TN; Bethel CR; Papp-Wallace KM; Logan LK; Perez F; Jacobs MR; van Duin D; Kreiswirth BM; Bonomo RA; Plummer MS; van den Akker F
J Med Chem; 2020 Jun; 63(11):5990-6002. PubMed ID: 32420736
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic resistance. Nosocomial gram-negative infection.
Gransden WR
J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
[No Abstract] [Full Text] [Related]
34. A step closer to extreme drug resistance (XDR) in gram-negative bacilli.
Paterson DL; Doi Y
Clin Infect Dis; 2007 Nov; 45(9):1179-81. PubMed ID: 17918079
[No Abstract] [Full Text] [Related]
35. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
Dimitriades K; Morrow BM; Jeena P
Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea.
Nam HM; Lim SK; Kim JM; Joo YS; Jang KC; Jung SC
Foodborne Pathog Dis; 2010 Feb; 7(2):221-4. PubMed ID: 19895257
[TBL] [Abstract][Full Text] [Related]
37. N-azamonobactams. 2. Synthesis of some N-iminoacetic acid and N-glycyl analogues.
Curran WV; Lenhard RH
J Med Chem; 1989 Aug; 32(8):1749-53. PubMed ID: 2754701
[TBL] [Abstract][Full Text] [Related]
38. Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?
Bolla JM; Brunel JM
Future Med Chem; 2014; 6(17):1849-51. PubMed ID: 25495978
[No Abstract] [Full Text] [Related]
39. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC
J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
